Carbapenem-Resistant Pseudomonas aeruginosa with Acquired blavim Metallo-ß-Lactamase Determinants, Italy
Open Access
- 1 June 2000
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 6 (3) , 312-313
- https://doi.org/10.3201/eid0603.000314
Abstract
Volume 22, Number 8—August 2016 - Emerging Infectious Disease journal - CDCThis publication has 9 references indexed in Scilit:
- Carbapenem-hydrolyzing metallo-beta-lactamases in Pseudomonas aeruginosa.European Journal of Clinical Microbiology & Infectious Diseases, 1999
- Cloning and Characterization of bla VIM , a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical IsolateAntimicrobial Agents and Chemotherapy, 1999
- Carbapenem-hydrolysing β-lactamase from clinical isolates of Pseudomonas aeruginosa in PortugalJournal of Antimicrobial Chemotherapy, 1999
- Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from SingaporeThe Lancet, 1999
- Appearance of IMP-1 metallo-β-lactamase in EuropeThe Lancet, 1999
- Carbapenemase-producing Pseudomonas aeruginosa in UKThe Lancet, 1998
- Acquired carbapenemasesJournal of Antimicrobial Chemotherapy, 1997
- Carbapenem-hydrolyzing beta-lactamasesAntimicrobial Agents and Chemotherapy, 1997
- Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenemsAntimicrobial Agents and Chemotherapy, 1996